These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5714998)

  • 1. Some observations on the cause of the gastric hypersecretion following portacaval shunt.
    McPhedran NT; Bett HD; Stone RM; Goldberg M
    Bull Soc Int Chir; 1968; 27(4):286-90. PubMed ID: 5714998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology of gastric hypersecretion after portacaval anastomosis].
    Ectors P; Limbosch JM; De Graef J
    Acta Gastroenterol Belg; 1971 Feb; 34(2):232-40. PubMed ID: 5565414
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous origin of the humoral agent responsible for gastric hypersecretion associated with portacaval shunt.
    Villar-Valdes H; Thompson AG; Rosen H; Chandler JG; Orloff MJ
    Surg Forum; 1969; 20():360-2. PubMed ID: 5383087
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased gastric synthesis of histamine: a possible mechanism for the gastric acid hypersecretion following portacaval shunt.
    Fischer JE; Snyder SH
    Fed Proc; 1965; 24(6):1334-40. PubMed ID: 5322507
    [No Abstract]   [Full Text] [Related]  

  • 5. Nature of the gastric hypersecretion associated with intestinal exclusion.
    Villar H; Abbott AG; Williams RJ; Rosen H; Orloff MJ
    Surg Forum; 1971; 22():299-300. PubMed ID: 5121380
    [No Abstract]   [Full Text] [Related]  

  • 6. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt.
    Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H
    Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum gastrin, gastrointestinal tissue gastrin, gastric hypersecretion after portacaval shunt in rats.
    Reichle FA; Reeder DD; Reichle RM; Thompson JC
    Surg Forum; 1974; 25(0):418-20. PubMed ID: 4439213
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum gastrin-like activity following portacaval shunt in dogs.
    Wilken BJ; Hunt DG; Hardy JD
    Br J Surg; 1969 Sep; 56(9):695. PubMed ID: 5808390
    [No Abstract]   [Full Text] [Related]  

  • 9. Peptic ulcer disease and gastric hypersecretion following portacaval shunt.
    Gudis S
    Mt Sinai J Med; 1976; 43(5):593-601. PubMed ID: 1086969
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased histamine synthesis: a possible final common pathway in gastric acid hypersecretion.
    Fischer JE; Snyder SH
    Surg Forum; 1965; 16():331-2. PubMed ID: 5835179
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral mediation of the intestinal phase of gastric secretion and of acid hypersecretion associated with portacaval suhunts.
    Orloff MJ; Villar-Valdes H; Rosen H; Thompson AG; Chandler JG
    Surgery; 1969 Jul; 66(1):118-30. PubMed ID: 5788367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the study of acid hypersecretion of the stomach after portacaval transposition in the dog].
    Hubens A
    Acta Gastroenterol Belg; 1966 Nov; 29(11):1008-37 contd. PubMed ID: 5990092
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of experimental liver disease and portacaval shunts on gastric acid secretion and blood histamine.
    Windsor CW; Thompson JC; Orloff MJ
    Surg Forum; 1965; 16():322-4. PubMed ID: 5835175
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolic changes after portacaval shunt.
    Martini GA
    Acta Gastroenterol Belg; 1971 Feb; 34(2):216-31. PubMed ID: 5565413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Morphological changes in the stomach in portocaval anastomosis in dogs].
    Rudenskaia MV
    Eksp Khir Anesteziol; 1967; 12(2):34-8. PubMed ID: 5618922
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of origin of the hormone responsible for gastric hypersecretion in humans with portacaval shunts.
    Abbott AG; Rosen H; Orloff MJ
    Surg Forum; 1970; 21():340-3. PubMed ID: 5514758
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of portacaval shunting on postprandial serum gastrin levels in dogs.
    Clendinnen BG; Reeder DD; Jackson BM; Miller JH; Thompson JC
    Surg Forum; 1970; 21():339-40. PubMed ID: 5514757
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric secretagogues following portacaval shunting.
    Griffen WO; Slesh MZ; Mooney CS
    Surgery; 1969 Jul; 66(1):111-7. PubMed ID: 5788366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of portacaval shunt on gastric secretion in cirrhotic dogs].
    Storace R
    Chir Patol Sper; 1965; 13(5):178-82. PubMed ID: 5887290
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the site of origin of the agent causing hypersecretion in dogs with portacaval shunt.
    CLARKE JS; McKISSOCK PK; CRUZE K
    Surgery; 1959 Jul; 46(1):48-55. PubMed ID: 13668814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.